Update on the Myriad (gene patent) case

There has been movement on an important gene patent case that we have followed in the past, the “Myriad” case. For more information take your pick from a range of posts on the subject on Patent Docs

PatentlyO summarised, “Guest Post: An Interesting Preview of Myriad?

“The Myriad case from the Southern District of New York, involving patent eligibility of DNA isolates derived from naturally occurring DNA, drew a great deal of attention. The court basically held such isolates ineligible for patent coverage as being too similar to the natural substances, and hence barred by the product-of-nature case law.”

This sounds like good news?  Well, even if it were as simple as that, it’s not over yet.  The case is now on appeal at the Federal Circuit. To be continued…

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s